[Single-donor platelet concentrate in patients with thrombocytopenia]
Secco A, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A.
Record ID 32018001400
Spanish
Authors' recommendations:
CONCLUSIONS
Very low quality evidence does not allow determining if single-donor platelet concentrates reduce transfusion-related viral and bacterial infections, and minor allergic reactions, when compared with platelet concentrates from multiple-donor whole blood. In the case of transfusion-related pulmonary injury both preparations might have similar risk. Most clinical practice guidelines consider both alternatives as valid. Most of the coverage policies consulted do not make specific reference to single-donor platelet apheresis.
Even though no cost-effectiveness, financial or organizational impact studies have been found, its cost is not high when compared with its comparator and the expected financial impact is not significant; therefore, it might have a reasonable cost-effectiveness.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
https://www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Thrombocytopenia
- Platelet Transfusion
- Blood Platelets
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.